Short description
Genesis Therapeutics unifies AI and biotech to accelerate the discovery of new medicines.
Description
Genesis Therapeutics is a company that has its roots in academic research, which serves as the foundational element of its growing portfolio of AI technologies. The company employs a combination of innovative deep neural networks, biophysical simulation techniques, and highly scalable computing infrastructure. This amalgamation of technologies is geared towards achieving remarkable results in molecular generation and property prediction, particularly in the field of drug discovery and molecular design.
Established in 2019 and headquartered in South San Francisco, California, Genesis Therapeutics focuses on leveraging innovative AI methodologies to enhance the efficiency and accuracy of molecular research. The company's approach holds promise in revolutionizing how molecules are generated and analyzed, potentially leading to advancements in drug development and related fields.
Last funding
Nopepepe
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
South San Francisco, California, United States, North America
Founded on
November 1, 2019
Non-profit?
No
Acquired?
No
Employees count
11-50
Investors
No Way, Noaccess, Uh Ohhhh, No Way, Cannot Access, Absolutely Noaccess, Cannot Access, Blurry Noaccess, Absolutely Noaccess, Cannot Access, Blurry Noaccess, Nopepepe, Nopepepe, No Way, Noway Youcantaccess, Absolutely Noaccess, Blurry Noaccess
Sign in for full access
Founders
Ben Sklaroff, Evan Feinberg